These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 19766328

  • 1. Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis.
    Petersen T, Møller-Larsen A, Thiel S, Brudek T, Hansen TK, Christensen T.
    J Neuroimmunol; 2009 Oct 30; 215(1-2):108-16. PubMed ID: 19766328
    [Abstract] [Full Text] [Related]

  • 2. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.
    Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Møller-Larsen A.
    J Neuroimmunol; 2007 Feb 30; 183(1-2):175-88. PubMed ID: 17113160
    [Abstract] [Full Text] [Related]

  • 3. Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis.
    Petersen T, Møller-Larsen A, Ellermann-Eriksen S, Thiel S, Christensen T.
    J Neuroimmunol; 2012 Aug 15; 249(1-2):105-8. PubMed ID: 22608883
    [Abstract] [Full Text] [Related]

  • 4. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
    Brudek T, Christensen T, Hansen HJ, Petersen T, Møller-Larsen A.
    Scand J Immunol; 2008 Mar 15; 67(3):295-303. PubMed ID: 18261041
    [Abstract] [Full Text] [Related]

  • 5. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
    Christensen T.
    Rev Med Virol; 2005 Mar 15; 15(3):179-211. PubMed ID: 15782388
    [Abstract] [Full Text] [Related]

  • 6. Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis.
    Trabattoni D, Ferrante P, Fusi ML, Saresella M, Caputo D, Urnovitz H, Cazzullo CL, Clerici M.
    J Neurovirol; 2000 May 15; 6 Suppl 2():S38-41. PubMed ID: 10871783
    [Abstract] [Full Text] [Related]

  • 7. Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.
    Sellner J, Greeve I, Findling O, Kamm CP, Minten C, Engelhardt B, Grandgirard D, Leib SL, Mattle HP.
    Neurochem Int; 2008 Jul 15; 53(1-2):17-21. PubMed ID: 18524417
    [Abstract] [Full Text] [Related]

  • 8. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
    Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H.
    J Neuroimmunol; 2005 Mar 15; 160(1-2):195-203. PubMed ID: 15710473
    [Abstract] [Full Text] [Related]

  • 9. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct 15; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 10. Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
    Shapiro AM, Jack CS, Lapierre Y, Arbour N, Bar-Or A, Antel JP.
    Arch Neurol; 2006 Sep 15; 63(9):1296-9. PubMed ID: 16966508
    [Abstract] [Full Text] [Related]

  • 11. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep 15; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 12. Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis.
    Wiesemann E, Deb M, Hemmer B, Radeke HH, Windhagen A.
    Clin Immunol; 2008 Sep 15; 128(3):306-13. PubMed ID: 18539537
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection.
    Nakatsuji Y, Nakano M, Moriya M, Kishigami H, Tatsumi C, Tada S, Sadahiro S, Naka T, Mitani K, Funauchi M, Azuma T, Watanabe S, Kinoshita M, Kajiyama K, Yuasa Y, Kaido M, Takahashi MP, Naba I, Hazama T, Sakoda S, Osaka Neurological Research Consortium.
    Cytokine; 2006 Oct 15; 36(1-2):69-74. PubMed ID: 17161613
    [Abstract] [Full Text] [Related]

  • 14. Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?
    Drulovic J, Savic E, Pekmezovic T, Mesaros S, Stojsavljevic N, Dujmovic-Basuroski I, Kostic J, Vasic V, Mostarica Stojkovic M, Popadic D.
    J Neuroimmunol; 2009 Oct 30; 215(1-2):90-5. PubMed ID: 19695714
    [Abstract] [Full Text] [Related]

  • 15. Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis?
    Perron H, Perin JP, Rieger F, Alliel PM.
    J Neurovirol; 2000 May 30; 6 Suppl 2():S67-75. PubMed ID: 10871789
    [Abstract] [Full Text] [Related]

  • 16. Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.
    Cucci A, Barbero P, Clerico M, Ferrero B, Versino E, Contessa G, Demercanti S, Viglietta E, Di Liberto A, Vai AG, Durelli L.
    J Neuroimmunol; 2010 Sep 14; 226(1-2):150-7. PubMed ID: 20573405
    [Abstract] [Full Text] [Related]

  • 17. Human endogenous retroviruses in neurologic disease.
    Christensen T.
    APMIS; 2016 Sep 14; 124(1-2):116-26. PubMed ID: 26818266
    [Abstract] [Full Text] [Related]

  • 18. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.
    Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P, Mueller-Lantzsch N.
    J Neurovirol; 2008 Apr 14; 14(2):143-51. PubMed ID: 18444086
    [Abstract] [Full Text] [Related]

  • 19. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
    Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.
    J Immunol Methods; 2009 Sep 30; 349(1-2):9-17. PubMed ID: 19699205
    [Abstract] [Full Text] [Related]

  • 20. Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation.
    Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M.
    Virology; 2001 Sep 01; 287(2):321-32. PubMed ID: 11531410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.